Acta Med. 2022, 65: 45-52
https://doi.org/10.14712/18059694.2022.17
High Flow Nasal Cannula Therapy in the Emergency Department: Main Benefits in Adults, Pediatric Population and against COVID-19: A Narrative Review
References
1. BK, Smallwood CD. Pediatric Oxygen Therapy: A Review and Update. Respir Care 2017; 62(6): 645–61.
<https://doi.org/10.4187/respcare.05245>
2. C, Alatorre-Jiménez MA, Johal V, Marín-Medina A, Kaur R, Esteban-Zubero E. Oxygen Therapy: Systems and Indications in the Pediatric and Adult Population. Iberoam J Med 2020; 2(3): 188–93.
<https://doi.org/10.53986/ibjm.2020.0034>
3. H, Sztrymf B, Leroy C, Brun P, Dreyfuss D, Ricard JD. Humidified high flow nasal oxygen during respiratory failure in the emergency department: feasibility and efficacy. Respir Care 2012; 57(11): 1873–8.
<https://doi.org/10.4187/respcare.01575>
4. JC, Walker DC, Knudson K, Dirks P, Dahlby RW, Hogg JC. Effect of breathing dry air on structure and function of airways. J Appl Physiol (1985) 1986; 61(1): 312–7.
<https://doi.org/10.1152/jappl.1986.61.1.312>
5. DJ, Tilles SA. Nasal physiological reactivity of subjects with nonallergic rhinitis to cold air provocation: a pilot comparison of subgroups. Am J Rhinol Allergy 2009; 23(5): 475–9.
<https://doi.org/10.2500/ajra.2009.23.3348>
6. MB, Li W, Wilker EH, Gold DR, Schwartz J, Zanobetti A, et alA. Association of outdoor temperature with lung function in a temperate climate. Eur Respir J 2019; 53(1): 1800612.
<https://doi.org/10.1183/13993003.00612-2018>
<PubMed>
7. A, Zhu Y, Wang J, Mosko JJ, Rodriguez E, Shaffer TH. The effects of gas humidification with high-flow nasal cannula on cultured human airway epithelial cells. Pulm Med 2012; 2012: 380686.
<https://doi.org/10.1155/2012/380686>
<PubMed>
8. EJ, Baker MD, Crites-Silver P. Subjective effects of humidification of oxygen for delivery by nasal cannula. A prospective study. Chest 1988; 93(2): 289–93.
<https://doi.org/10.1378/chest.93.2.289>
9. Z, Wang W, Zhang H, Wu C, Ding J, Shen M. Is humidified better than non-humidified low-flow oxygen therapy? A systematic review and meta-analysis. J Adv Nurs 2017; 73(11): 2522–33.
<https://doi.org/10.1111/jan.13323>
10. L, Piquilloud L, Seegers V, Le Roy C, Colonval K, Agasse Cet al. Effect on comfort of administering bubble-humidified or dry oxygen: the Oxyrea non-inferiority randomized study. Ann Intensive Care 2018; 8(1): 126.
<https://doi.org/10.1186/s13613-018-0472-9>
<PubMed>
11. SD, Alladina JW, Hibbert KA, Harris RS, Bajwa EK, Hess DR. High-flow oxygen therapy and other inhaled therapies in intensive care units. Lancet 2016; 387(10030): 1867–78.
<https://doi.org/10.1016/S0140-6736(16)30245-8>
12. CC, Lan HM, Li CJ, Lee TH, Chen WL, Lei WY, et al. Use High-Flow Nasal Cannula for Acute Respiratory Failure Patients in the Emergency Department: A Meta-Analysis Study. Emerg Med Int 2019; 2019: 2130935.
13. M. High-Flow Nasal Cannula Oxygen Therapy in Adults: Physiological Benefits, Indication, Clinical Benefits, and Adverse Effects. Respir Care 2016; 61(4): 529–41.
<https://doi.org/10.4187/respcare.04577>
14. M. High-flow nasal cannula oxygen therapy in adults. J Intensive Care 2015; 3(1): 15.
<https://doi.org/10.1186/s40560-015-0084-5>
<PubMed>
15. JL, Wakai A, Collins SP, Levy PD, Diercks D, Hiestand BC, et al. Diagnosing Acute Heart Failure in the Emergency Department: A Systematic Review and Meta-analysis. Acad Emerg Med 2016; 23(3): 223–42.
<https://doi.org/10.1111/acem.12878>
16. AB, Jenkins CA, Self WH, Alexander PT, Barrett TW, Han JH, et al. The burden of acute heart failure on U.S. emergency departments. JACC Heart Fail 2014; 2(3): 269–77.
<https://doi.org/10.1016/j.jchf.2014.01.006>
<PubMed>
17. A, Pang PS, Tavares M, Collins SP, Storrow AB, Laribi S, et al. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur Heart J 2010; 31(7): 832–41.
<https://doi.org/10.1093/eurheartj/ehp458>
18. JJ, Choi DJ, Yoon CH, Oh IY, Lee JH, Ahn S, et al. The prognostic value of arterial blood gas analysis in high-risk acute heart failure patients: an analysis of the Korean Heart Failure (KorHF) registry. Eur J Heart Fail 2015; 17(6): 601–11.
<https://doi.org/10.1002/ejhf.276>
19. AM, Sulaiman K, Alsheikh-Ali AA, Singh R, AlHabib KF, Al-Zakwani I, et al. Precipitating Factors for Hospitalization with Heart Failure: Prevalence and Clinical Impact Observations from the Gulf CARE (Gulf aCute heArt failuRe rEgistry). Med Princ Pract 2020; 29(3): 270–8.
<https://doi.org/10.1159/000503334>
<PubMed>
20. RL, McGuinness SP. Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle. Respir Care 2013; 58(10): 1621–4.
<https://doi.org/10.4187/respcare.02358>
21. JH, Rehder KJ, Williford L, Cheifetz IM, Turner DA. Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature. Intensive Care Med 2013; 39(2): 247–57.
<https://doi.org/10.1007/s00134-012-2743-5>
22. JM, Llorens P, Brouzet B, Albert Jiménez AR, Fernández-Cañadas JM, Carbajosa Dalmau J, et al. High-Flow therapy via nasal cannula in acute heart failure. Rev Esp Cardiol 2011; 64(8): 723–5.
<https://doi.org/10.1016/j.recesp.2010.10.034>
23. JM, Díaz Lobato S, Brouzet B, Más-Serrano P, Espinosa B, Llorens P. Efficacy and safety of high-flow nasal cannula oxygen therapy in patients with acute heart failure. Emergencias 2018; 30(6): 395–9.
24. DR, Beom J, Lee HS, You JS, Chung HS, Chung SP. Benefits of High-Flow Nasal Cannula Therapy for Acute Pulmonary Edema in Patients with Heart Failure in the Emergency Department: A Prospective Multi-Center Randomized Controlled Trial. J Clin Med 2020; 9(6): 1937.
<https://doi.org/10.3390/jcm9061937>
<PubMed>
25. N, Alemayehu W, Rowe BH, McAlister FA, van Diepen S, Stickland M, et al. High vs. low oxygen therapy in patients with acute heart failure: HiLo-HF pilot trial. ESC Heart Fail 2019; 6(4): 667–77.
<https://doi.org/10.1002/ehf2.12448>
<PubMed>
26. Vital FM, Saconato H, Ladeira MT, Sen A, Hawkes CA, Soares B, et al. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema. Cochrane Database Syst Rev 2008; (3): CD005351.
27. W, Iglesias C, Vera S, Marcos M, Uribarri A, Gómez I, et al. Prognostic impact of high flow nasal cannula compared to noninvasive positive-pressure ventilation in the treatment of acute pulmonary edema. Rev Port Cardiol (Engl Ed) 2021; 40(9): 703–5.
<https://doi.org/10.1016/j.repc.2021.04.004>
28. N, Flacher A, Drouet L, Gouhinec AL, Said H, Vigneau JF, et al. High-Flow Nasal Cannula in Early Emergency Department Management of Acute Hypercapnic Respiratory Failure Due to Cardiogenic Pulmonary Edema. Respir Care 2020; 65(9): 1241–9.
<https://doi.org/10.4187/respcare.07278>
29. MG, Kim K, Ju S, Park HW, Lee SJ, Koh JS, et al. Clinical efficacy of high-flow oxygen therapy through nasal cannula in patients with acute heart failure. J Thorac Dis 2019; 11(2): 410–7.
<https://doi.org/10.21037/jtd.2019.01.51>
<PubMed>
30. J, Peacock WF, Price S, Cullen L, Martin-Sanchez FJ, Seferovic P, et al. Indications and practical approach to non-invasive ventilation in acute heart failure. Eur Heart J 2018; 39(1): 17–25.
<https://doi.org/10.1093/eurheartj/ehx580>
<PubMed>
31. RN, Han MK. COPD Care in the 21st Century: A Public Health Priority. Respir Care 2018; 63(5): 591–600.
<https://doi.org/10.4187/respcare.06276>
<PubMed>
32. B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017; 50(2): 1602426.
<https://doi.org/10.1183/13993003.02426-2016>
33. L, Vega ML. Use of nasal high flow in stable COPD: rationale and physiology. COPD 2017; 14(3): 346–50.
<https://doi.org/10.1080/15412555.2017.1315715>
34. J, Eastlake L, Richards M, Power S, Cripps T, Bibby S, et al. Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: A randomized controlled cross-over trial. Respirology 2017; 22(6): 1149–55.
<https://doi.org/10.1111/resp.13050>
35. J, Wirtz H. Nasal high-flow in acute hypercapnic exacerbation of COPD. Int J Chron Obstruct Pulmon Dis 2018; 13: 3895–7.
<https://doi.org/10.2147/COPD.S185001>
<PubMed>
36. A, Longhini F, Carlucci A, Scala R, Groff P, Bruni A, et al. High-flow nasal therapy versus noninvasive ventilation in COPD patients with mild-to-moderate hypercapnic acute respiratory failure: study protocol for a noninferiority randomized clinical trial. Trials 2019; 20(1): 450.
<https://doi.org/10.1186/s13063-019-3514-1>
<PubMed>
37. J, Li Y, Ling B, Zhu Q, Hu Y, Tan D, et al. High flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: an observational cohort study. Int J Chron Obstruct Pulmon Dis 2019; 14: 1229–37.
<https://doi.org/10.2147/COPD.S206567>
<PubMed>
38. L, Zhou L, Liu H, Wang J. Outcomes of high-flow nasal cannula versus non-invasive positive pressure ventilation for patients with acute exacerbations of chronic obstructive pulmonary disease. Int J Clin Exp Med 2019; 12(8): 10863–7.
39. MK, Choi J, Park B, Kim B, Lee SJ, Kim SH, et al. High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure. Clin Respir J 2018; 12(6): 2046–56.
<https://doi.org/10.1111/crj.12772>
40. E, Dimakou K, Hurst J, Martinez-Garcia MA, Miravitlles M, Paggiaro P, et al. The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. Eur Respir J 2018; 52(3): 1800328.
<https://doi.org/10.1183/13993003.00328-2018>
41. C, Ferri S, Crimi N. Bronchiectasis and asthma: a dangerous liaison? Curr Opin Allergy Clin Immunol 2019; 19(1): 46–52.
<https://doi.org/10.1097/ACI.0000000000000492>
42. Y, Shi G, Yu Y, Hao J, Chen T, Song H. Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 2015; 10: 1465–75.
<https://doi.org/10.2147/COPD.S83910>
<PubMed>
43. C, Noto A, Cortegiani A, Campisi R, Heffler E, Gregoretti C, et al. High Flow Nasal Therapy Use in Patients with Acute Exacerbation of COPD and Bronchiectasis: A Feasibility Study. COPD 2020; 17(2): 184–90.
<https://doi.org/10.1080/15412555.2020.1728736>
44. PA, Wise SK. Epidemiology of asthma. Curr Opin Otolaryngol Head Neck Surg 2016; 24(3): 245–9.
<https://doi.org/10.1097/MOO.0000000000000262>
45. K, Sugino K, Hojyo T, Ishida F, Sano G, Isobe K, et al. Clinical evaluation of severe asthma attacks requiring tracheal intubation and mechanical ventilation. Allergol Int 2009; 58(2): 289–94.
<https://doi.org/10.2332/allergolint.08-OA-0052>
46. RD, Tate A, Gardner DD, Wittnebel LD, Wettstein R, Khusid F. Current approaches to the assessment and treatment of acute severe asthma. Indian J Respir Care 2015; 4(1): 2015.
47. S, Fakharian A, Ghorbani F, Jamaati HR, Mirenayat MS. Value and Safety of High Flow Oxygenation in the Treatment of Inpatient Asthma: A Randomized, Double-blind, Pilot Study. Iran J Allergy Asthma Immunol 2019; 18(6): 615–23.
48. W, Batu W, You S, Tong Z, He H. High-Flow Nasal Cannula: A Promising Oxygen Therapy for Patients with Severe Bronchial Asthma Complicated with Respiratory Failure. Can Respir J 2020; 2020: 2301712.
49. J, Modesto I Alapont V, Lopez-Fernandez YM, Lopez-Macias O, Garcia-Urabayen D, Amores-Hernandez I. High-flow nasal cannula therapy versus non-invasive ventilation in children with severe acute asthma exacerbation: An observational cohort study. Med Intensiva 2017; 41(7): 418–24.
<https://doi.org/10.1016/j.medin.2017.01.001>
50. F, Buisson A, Vanel B, Massenavette B, Pouyau R, Javouhey E. Nasal high flow in management of children with status asthmaticus: a retrospective observational study. Ann Intensive Care 2017; 7(1): 55.
<https://doi.org/10.1186/s13613-017-0278-1>
<PubMed>
51. Y, De Pedro J, Portillo N, Martinez-Mugica O, Arana-Arri E, Benito J. Pilot Clinical Trial of High-Flow Oxygen Therapy in Children with Asthma in the Emergency Service. J Pediatr 2018; 194: 204–210.e3.
<https://doi.org/10.1016/j.jpeds.2017.10.075>
52. F, González Sánchez MI, Toledo Del Castillo B, Pérez Moreno J, Medina Muñoz M, Rodríguez Jiménez C, et al. [Treatment with high-flow oxygen therapy in asthma exacerbations in a paediatric hospital ward: Experience from 2012 to 2016]. An Pediatr (Barc) 2019; 90(2): 72–8.
<https://doi.org/10.1016/j.anpedi.2018.06.015>
53. R, Morilla Sanabria LP, Pavlicich V, Mesquita M. High flow nasal cannula oxygen therapy in patients with asthmatic crisis in the pediatric emergency department. Rev Chil Pediatr 2019; 90(6): 642–8.
54. L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, et al. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet 2016; 388(10063): 3027–35.
<https://doi.org/10.1016/S0140-6736(16)31593-8>
<PubMed>
55. MJ, Salam MA, Smith JH, Ahmed T, Pietroni MA, Shahunja KM, et al. Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh: an open, randomised controlled trial. Lancet 2015; 386(9998): 1057–65.
<https://doi.org/10.1016/S0140-6736(15)60249-5>
56. O, Riera J, Torres F, Masclans JR. High-flow oxygen therapy in acute respiratory failure. Respir Care 2010; 55(4): 408–13.
57. JP, Ragot S, Thille AW. High-Flow Nasal Cannula Oxygen in Respiratory Failure. N Engl J Med 2015; 373(14): 1374–5.
58. J, Marjanovic N, Faranpour F, Mimoz O, Frerebeau M, Violeau M, et al. Early high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure in the ED: A before-after study. Am J Emerg Med 2019; 37(11): 2091–6.
<https://doi.org/10.1016/j.ajem.2019.03.004>
59. B, Messika J, Mayot T, Lenglet H, Dreyfuss D, Ricard JD. Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: a prospective observational study. J Crit Care 2012; 27(3): 324.e9–13.
<https://doi.org/10.1016/j.jcrc.2011.07.075>
60. O, Messika J, Caralt B, García-de-Acilu M, Sztrymf B, Ricard JD, et al. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index. J Crit Care 2016; 35: 200–5.
<https://doi.org/10.1016/j.jcrc.2016.05.022>
61. DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 1999; 282(15): 1440–6.
<https://doi.org/10.1001/jama.282.15.1440>
62. P, Brandenburg N, Carter B. The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations. Arch Pediatr Adolesc Med 2001; 155(1): 95–6.
<https://doi.org/10.1001/archpedi.155.1.95>
63. Y, Prieur G, LE Roux P, Médrinal C. Non-invasive ventilation improves respiratory distress in children with acute viral bronchiolitis: a systematic review. Minerva Anestesiol 2017; 83(6): 624–37.
<https://doi.org/10.23736/S0375-9393.17.11708-6>
64. F, González Sánchez MI, Rodríguez Fernández R. [Clinical impact of introducing ventilation with high flow oxygen in the treatment of bronchiolitis in a paediatric ward]. An Pediatr (Barc) 2013; 78(4): 210–5.
<https://doi.org/10.1016/j.anpedi.2012.11.024>
65. J, Porter T, Fierce J, Riese A, Richardson T, Alverson BK. Clinical Outcomes of Bronchiolitis After Implementation of a General Ward High Flow Nasal Cannula Guideline. Hosp Pediatr 2017; 7(4): 197–203.
<https://doi.org/10.1542/hpeds.2016-0195>
66. D, Babl FE, Schlapbach LJ, Oakley E, Craig S, Neutze J, et al. A Randomized Trial of High-Flow Oxygen Therapy in Infants with Bronchiolitis. N Engl J Med 2018; 378(12): 1121–31.
<https://doi.org/10.1056/NEJMoa1714855>
67. E, Fernández A, Ferrero F, Barbaro C, De Lillo L, Lavitola M, et al. High-flow nasal cannula oxygen therapy in infants with acute lower respiratory tract infection. An experience in hospitals of the City of Buenos Aires. Arch Argent Pediatr 2019; 117(5): 286–93.
68. E, Whitehead B, Attia J, Oldmeadow C, Collison A, Searles A, et al. High-flow warm humidified oxygen versus standard low-flow nasal cannula oxygen for moderate bronchiolitis (HFWHO RCT): an open, phase 4, randomised controlled trial. Lancet 2017; 389(10072): 930–9.
<https://doi.org/10.1016/S0140-6736(17)30061-2>
69. AB, Calıskan E, Samsa H, Gokcek I, Kaya A, Zararsiz GE, et al. Using a high-flow nasal cannula provides superior results to OxyMask delivery in moderate to severe bronchiolitis: a randomized controlled study. Eur J Pediatr 2018; 177(8): 1299–307.
<https://doi.org/10.1007/s00431-018-3191-1>
70. P, Bridier A, Josseran L, Mbieleu B, Hammami W, Bergounioux J. High-flow nasal cannula use for bronchiolitis treatment in French intensive care units: A transversal study. Arch Pediatr 2019; 26(3): 174–5.
<https://doi.org/10.1016/j.arcped.2019.02.002>
71. S, Jürgensen L, la Cour A, Markoew S, Petersen TH, Kofoed PE. High flow nasal cannula and continuous positive airway pressure therapy in treatment of viral bronchiolitis: a randomized clinical trial. Eur J Pediatr 2020; 179(3): 513–8.
<https://doi.org/10.1007/s00431-019-03533-2>
72. World Health Organization. Coronavirus disease (COVID-19) Situation Report. (Accessed May 13, 2021, at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20210511_weekly_epi_update_39.pdf?sfvrsn=b66ba70d_11&download=true.)
73. Kaya A, Öz M, Erol S, Çiftçi F, Çiledağ A, Kaya A. High flow nasal cannula in COVID-19: a literature review. Tuberk Toraks 2020; 68(2): 168–74.
<https://doi.org/10.5578/tt.69807>
74. KJ, Choong MC, Cheong EH, Kalimuddin S, Duu Wen S, Phua GC, et al. Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from COVID-19 Infection. Ann Acad Med Singap 2020; 49(3): 108–18.
<https://doi.org/10.47102/annals-acadmedsg.202057>
75. KE, Lin JC, Verhoef PA. High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients. Crit Care 2020; 24(1): 169.
<https://doi.org/10.1186/s13054-020-02892-9>
<PubMed>
76. S, Mei Q, Zhu C, Yang T, Yang Y, Fang X, et al. High flow nasal cannula is a good treatment option for COVID-19. Heart Lung 2020; 49(5): 444–5.
<https://doi.org/10.1016/j.hrtlng.2020.03.018>
<PubMed>
77. K, Zhao W, Li J, Shu W, Duan J. The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China. Ann Intensive Care 2020; 10(1): 37.
<https://doi.org/10.1186/s13613-020-00653-z>
<PubMed>
78. M, Gangemi A, Marron R, Chowdhury J, Yousef I, Zheng M, et al. Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure. BMJ Open Respir Res 2020; 7(1): e000650.
<https://doi.org/10.1136/bmjresp-2020-000650>
<PubMed>
79. M, Zhou Q, Zheng R, Li X, Ling J, Chen Y, et al. Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study. BMC Pulm Med 2020; 20(1): 324.
<https://doi.org/10.1186/s12890-020-01354-w>
<PubMed>
80. R, Mujica LE, Ruiz ML, Ferreyro BL, Angriman F, Arruti E, et al. Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study. J Intensive Care 2021; 9(1): 23.
<https://doi.org/10.1186/s40560-021-00538-8>
<PubMed>
81. JC, Amrane S, Mailhe M, Gainnier M, Arlotto S, Gentile S, et al. High-flow oxygen therapy in elderly patients infected with SARS-CoV2 with a contraindication for transfer to an intensive care unit: a preliminary report. Int J Infect Dis 2021: S1201-9712(21)00305-2.
82. A, Vieillard Baron A, Darmon M, Beurton A, Géri G, Voiriot G, et al. High-Flow Nasal Cannula in Critically III Patients with Severe COVID-19. Am J Respir Crit Care Med 2020; 202(7): 1039–42.
<https://doi.org/10.1164/rccm.202005-2007LE>
<PubMed>
83. R, Ferreyro BL, Angriman F, Hernández-Sanz M, Arruti E, Torres A, et al. High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure. Crit Care 2021; 25(1): 58.
<https://doi.org/10.1186/s13054-021-03469-w>
<PubMed>
84. N, Martin O, Boubaya M, Levy V, Ebstein N, Karoubi P, et al. High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study. Ann Intensive Care 2021; 11(1): 37.
<https://doi.org/10.1186/s13613-021-00825-5>
<PubMed>
85. C, Grosse A, Salzer HJF, Dünser MW, Motz R, Langer R. Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia. Cardiovasc Pathol 2020; 49: 107263.
<https://doi.org/10.1016/j.carpath.2020.107263>
<PubMed>
86. SF, Skok K, Zechner P, Kessler HH, Kaufmann N, Koelblinger C, et al. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series. Ann Intern Med 2020; 173(5): 350–61.
<https://doi.org/10.7326/M20-2566>
<PubMed>
87. SGE. Using the prone position could help to combat the development of fast hypoxia in some patients with COVID-19. Acta Paediatr 2020; 109(8): 1539–44.
<https://doi.org/10.1111/apa.15382>
<PubMed>
88. Q, Wang T, Qin X, Jie Y, Zha L, Lu W. Early awake prone position combined with high-flow nasal oxygen therapy in severe COVID-19: a case series. Crit Care 2020; 24(1): 250.
<https://doi.org/10.1186/s13054-020-02991-7>
<PubMed>
89. M, Cheng J, Ondrejicka M, Arntfield R; Critical Care Western Research Group. Patient self-proning with high-flow nasal cannula improves oxygenation in COVID-19 pneumonia. Can J Anaesth 2020; 67(9): 1288–90.
<https://doi.org/10.1007/s12630-020-01661-0>
<PubMed>
90. GW, Liao YX, Li QY, Dong H, Yang LY, Zhang XY, et al. Prone positioning in high-flow nasal cannula for COVID-19 patients with severe hypoxemia: a pilot study. Ann Transl Med 2020; 8(9): 598.
<https://doi.org/10.21037/atm-20-3005>
<PubMed>
91. C, Brunin Y, Berthier F, Pili-Floury S, Besch G. Prone positioning combined with high-flow nasal or conventional oxygen therapy in severe Covid-19 patients. Crit Care 2020; 24(1): 256.
<https://doi.org/10.1186/s13054-020-03001-6>
<PubMed>
92. H, Davies R, Ma D. Potential therapeutic value of dexmedetomidine in COVID-19 patients admitted to ICU. Br J Anaesth 2021; 126(1): e33–e35.
<https://doi.org/10.1016/j.bja.2020.09.031>
<PubMed>
93. M, Baluja A, Santos LD, González I, Veiras S, Caruezo V, et al. Effectiveness of dexmedetomidine combined with high flow nasal oxygen and long periods of awake prone positioning in moderate or severe COVID-19 pneumonia. J Clin Anesth 2021; 72: 110261.
<https://doi.org/10.1016/j.jclinane.2021.110261>
<PubMed>
94. A, Hernández-Garcés H. Failure of non-invasive ventilation after use of high-flow oxygen therapy in patients with SARS-Coronavirus-2 pneumonia. Med Intensiva 2020; S0210-5691(20)30220-30225.
95. BJ, Koh Y, Lim CM, Huh JW, Baek S, Han M, et al. Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med 2015; 41(4): 623–32.
<https://doi.org/10.1007/s00134-015-3693-5>
96. C, Boubal M, Jacquot A, Baleine J, Durand S, Odena MP, et al. High-flow nasal cannula: recommendations for daily practice in pediatrics. Ann Intensive Care 2014; 4: 29.
<https://doi.org/10.1186/s13613-014-0029-5>
<PubMed>
97. Turner E, Jenks M. Cost-effectiveness analysis of the use of high-flow oxygen through nasal cannula in intensive care units in NHS England. Expert Rev Pharmacoecon Outcomes Res 2018; 18(3): 331–7.
<https://doi.org/10.1080/14737167.2018.1411804>
98. P, Forma L, Korppi M. High-flow oxygen therapy is more cost-effective for bronchiolitis than standard treatment-A decision-tree analysis. Pediatr Pulmonol 2016; 51(12): 1393–402.
<https://doi.org/10.1002/ppul.23467>
